XTL Biopharmaceuticals Ltd: Form 6-K, filed Dec 12, 2013
Filed with the SEC on Dec 12, 2013 and accepted by EDGAR at Dec 12, 2013, 22:01 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001144204-13-066992. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.